Belgium's IBA signs three deals in Asia


BRUSSELS, Oct 11 (Reuters) - Belgian cancer diagnosis andtherapy company IBA has signed three deals in Asiaworth a total of 10 million euros ($12.90 million) for the saleof specialised sterilisation units, it said on Thursday.

The group did not specify where in Asia it has sold itssterilisation units, which operate without leaving traces ofchemical or radioactive contamination on the medical devicesbeing sterilised.

IBA said it has sold more than 30 of the units worldwide.

Additional sales in 2012 should push the group's revenuegrowth to the top of the 5-10 percent guidance range, it said inAugust.

IBA made a net loss of 1.4 million euros in the first halfof 2012, hit by a one-off charge related to a contract dispute.

($1 = 0.7751 euros)

(Reporting By Robert-Jan Bartunek; Editing by Matt Driskill)

((robertjan.bartunek@thomsonreuters.com)(+32 2 2876850))

Keywords: IBA ASIA/